Ubiquitin-dependent degradation of cyclin B is accelerated in polyploid megakaryocytes

被引:70
作者
Zhang, Y
Wang, ZY
Liu, DX
Pagano, M
Ravid, K
机构
[1] Boston Univ, Sch Med, Dept Biochem, Whitaker Cardiovasc Inst, Boston, MA 02118 USA
[2] NYU, Med Ctr, New York, NY 10016 USA
[3] NYU, Kaplan Canc Ctr, New York, NY 10016 USA
关键词
D O I
10.1074/jbc.273.3.1387
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During the endomitotic cell cycle of megakaryocytic cell lines, the levels of cyclin B1 and the activity of cyclin B1-dependent Cdc2 kinase, although detectable, are reduced as compared with megakaryocytes undergoing a mitotic cell cycle, The levels of cyclin A, however, are comparable during both cell cycles, The expression of cyclin B1 mRNA is also equivalent in proliferating and polyploidizing cells, In the current study, we found that the rate of cyclin B1 protein degradation is enhanced in polyploidizing megakaryocytes, This finding has led us to further investigate whether the ubiquitin-proteosome pathway responsible for cyclin B degradation is accelerated in these cells, Our data indicate that polyploidizing megakaryocytic cell lines and primary bone marrow cells treated with the megakaryocyte proliferation-and ploidy-promoting factor, the c-Mpl ligand, display increased activities of the ubiquitin-proteosome pathway, which degrades cyclin B, as compared with proliferating megakaryocytic cell lines or diploid bone marrow cells, respectively. This degradation has all the hallmarks of a ubiquitin pathway, including the dependence on ATP, the appearance of high molecular weight conjugated forms of cyclin B, and inhibition of the proteolytic process by a mutated form of the ubiquitin-conjugating enzyme Ubc4., Our studies also indicate that the ability to degrade cyclin A is equivalent in both the mitotic and endomitotic cell cycles, The increased potential of polyploid megakaryocytes to degrade cyclin B may be part of the cellular programming that leads to aborted mitosis.
引用
收藏
页码:1387 / 1392
页数:6
相关论文
共 42 条
  • [1] BURSTEIN SA, 1992, EXP HEMATOL, V20, P1170
  • [2] CARROW CE, 1996, BLOOD, V88, P287
  • [3] THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY
    CIECHANOVER, A
    [J]. CELL, 1994, 79 (01) : 13 - 21
  • [4] P25(RUM1) ORDERS S-PHASE AND MITOSIS BY ACTING AS AN INHIBITOR OF THE P34(CDC2) MITOTIC KINASE
    CORREABORDES, J
    NURSE, P
    [J]. CELL, 1995, 83 (06) : 1001 - 1009
  • [5] Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content
    Datta, NS
    Williams, JL
    Caldwell, J
    Curry, AM
    Ashcraft, EK
    Long, MW
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1996, 7 (02) : 209 - 223
  • [6] DATTA NS, 1993, BLOOD, V82, pA209
  • [7] DOI T, 1987, MOL CELL BIOL, V7, P898, DOI 10.1128/MCB.7.2.898
  • [8] GENERATION OF P50 SUBUNIT OF NF-KAPPA-B BY PROCESSING OF P105 THROUGH AN ATP-DEPENDENT PATHWAY
    FAN, CM
    MANIATIS, T
    [J]. NATURE, 1991, 354 (6352) : 395 - 398
  • [9] A single fission yeast mitotic cyclin B p34(cdc2) kinase promotes both S-phase and mitosis in the absence of G(1) cyclins
    Fisher, DL
    Nurse, P
    [J]. EMBO JOURNAL, 1996, 15 (04) : 850 - 860
  • [10] GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0